UCI is a public medical care facility in partnership with the Ministry of Health. UCI's main focus is on research, training, consultation, prevention and cancer treatment in areas of Paediatrics, Oncology, Gynaecology, Radiotherapy, surgery, pharmacy and recently venturing into bone marrow transplants. Patients also receive palliative care and rehabilitation services.
UCI is affiliated with the Makerere University School of medicine and with the Mulago hospital complex, the teaching hospital for the medical school. The Institute also partners with a wide array of investigators from Uganda and across the globe.
UCI aims to be an internationally recognised centre of excellence advancing comprehensive cancer management in Africa and to reduce the incidence of cancer and improve survival through excelling in prevention, care, research and training.
Cambridge-Africa is a University programme that supports African researchers and promotes mutually beneficial collaborations and equitable partnerships between Africa and Cambridge.
Established in 2007, the Cancer Research UK Cambridge Institute was the first major new cancer research centre in the UK for over 50 years. Based on the Cambridge Biomedical Campus, the goal of the CRUK Cambridge Institute is to combine world leading basic cancer biology with key technologies to bear on practical questions of cancer diagnosis, treatment and prevention.
The CRUK Cambridge Centre is a dynamic collaboration of researchers, clinicians, and the pharmaceutical and biotech industries based in the Cambridge area. They combine world-class science and technology with excellent patient care to pioneer new ways to prevent, detect and treat cancer.
The Cambridge Cancer Centre Paediatric Programme within the CRUK Cambridge Centre is particularly active in the collaboration with UCI. They work closely with the Department of Paediatric Haematology and Oncology at Addenbrookes Hospital.
Cancer is a major research interest in the University of Cambridge's Department of Pathology. Research within the Department aims both to unravel the normal processes of cell signalling, proliferation, differentiation and death and to identify what causes deviation from these normal patterns in cancer.
CGHP works with hospitals, governments and health organisations in countries across Africa, Asia and Latin America to provide specialist expertise, support shared learning and encourage sustainable change.